Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol
NCT01268878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130
Last updated 2014-01-03
Summary
The ending of this study is to describe the effect of febrile neutropenia on patients who receive a chemotherapy by docetaxel+cisplatin+fluorouracil(TPF).
Conditions
- Squamous Cell Head and Neck Carcinoma
Sponsors & Collaborators
-
Groupe Oncologie Radiotherapie Tete et Cou
lead OTHER
Principal Investigators
-
ROLLAND Frederic, MD · GORTEC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2011-11-30
- Completion
- 2011-11-30
Countries
- France
Study Locations
More Related Trials
-
Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC
NCT02268695 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer
NCT00273546 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT01086826 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00139269 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT05527782 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT00401323 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.
NCT01233843 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT01221753 ·Status: TERMINATED ·Phase: PHASE2
-
Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer
NCT01126216 ·Status: TERMINATED ·Phase: PHASE3
-
C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00402545 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00139230 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT01289522 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT01154920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy
NCT02216617 ·Status: COMPLETED ·Phase: PHASE1
-
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
NCT02201355 ·Status: TERMINATED ·Phase: PHASE1
-
Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN
NCT03117257 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurent Chemoradiotherapy in Head and Neck Cancers
NCT04780750 ·Status: UNKNOWN ·Phase: PHASE3
-
Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer
NCT03194061 ·Status: UNKNOWN ·Phase: NA
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00003888 ·Status: COMPLETED ·Phase: PHASE3
-
Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor
NCT04766827 ·Status: UNKNOWN ·Phase: PHASE4
-
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00625937 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
NCT01566435 ·Status: COMPLETED ·Phase: PHASE2
-
Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck
NCT02776137 ·Status: COMPLETED ·Phase: PHASE2
-
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
NCT00084435 ·Status: WITHDRAWN ·Phase: PHASE2
-
Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)
NCT00357149 ·Status: COMPLETED ·Phase: PHASE2